Mild hypertension in people at low risk
Department of Family Medicine and Community Health
Cardiovascular Diseases | Community Health and Preventive Medicine | Diagnosis | Family Medicine | Preventive Medicine | Primary Care | Therapeutics
Antihypertensive drugs have an important role in the treatment of malignant hypertension, secondary prevention of cardiovascular disease, and primary prevention for people at high risk: those with moderate to severe hypertension (≥160/100 mm Hg), diabetes, or chronic kidney disease. Debate continues, however, about the level at which treatment should begin and the appropriate targets for treatment. The greatest uncertainty surrounds mild hypertension (140-159/90-99 mm Hg), which accounts for over 60% of those with hypertension or 22% of the global adult population. Evidence suggests no net benefit from drug treatment of mild hypertension in people without the higher risks of diabetes or chronic kidney disease. Nevertheless, most people with mild hypertension are treated with drugs. In this article, we examine the overdiagnosis and overtreatment of mild hypertension.
DOI of Published Version
Martin SA, Boucher M, Wright JM, Saini V. Mild hypertension in people at low risk. BMJ. 2014 Sep 14;349:g5432. doi: 10.1136/bmj.g5432. PubMed PMID: 25224509.
BMJ (Clinical research ed.)
Martin SA, Boucher MK, Wright JM, Saini V. (2014). Mild hypertension in people at low risk. Family Medicine and Community Health Publications. https://doi.org/10.1136/bmj.g5432. Retrieved from https://escholarship.umassmed.edu/fmch_articles/317